TuisHAE • NYSE
add
Haemonetics Corp
Vorige sluiting
$70,40
Dagwisseling
$70,45 - $71,53
Jaarwisseling
$55,30 - $94,99
Markkapitalisasie
3,38 mjd USD
Gemiddelde volume
547,52 k
P/V-verhouding
21,32
Dividend-opbrengs
-
Primêre beurs
NYSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 330,60 m | -3,70% |
Bedryfskoste | 142,30 m | 1,97% |
Netto inkomste | 57,98 m | 184,68% |
Netto winsgrens | 17,54 | 195,78% |
Wins per aandeel | 1,24 | 37,78% |
EBITDA | 78,37 m | 14,51% |
Effektiewe belastingkoers | 18,03% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 308,07 m | 70,70% |
Totale bates | 2,45 mjd | 11,63% |
Totale aanspreeklikheid | 1,63 mjd | 31,93% |
Totale ekwiteit | 820,84 m | — |
Uitstaande aandele | 48,04 m | — |
Prys om te bespreek | 4,14 | — |
Opbrengs op bates | 5,71% | — |
Opbrengs op kapitaal | 6,61% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 57,98 m | 184,68% |
Kontant van bedrywe | 116,56 m | 81,89% |
Kontant van beleggings | 18,04 m | 238,17% |
Kontant van finansiering | -151,45 m | -138,50% |
Netto kontantverandering | -14,08 m | 7,21% |
Beskikbare kontantvloei | 114,90 m | 72,66% |
Meer oor
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
Gestig
1971
Hoofkwartier
Webwerf
Werknemers
3 023
